glycyl-arginyl-glycyl-aspartyl-seryl-proline has been researched along with Lung Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujita, S; Hirohashi, S; Kinoshita, M; Suzuki, H | 1 |
Bretti, S; Comoglio, P; Giancotti, F; Lozzi, L; Neri, P; Rustici, M; Tarone, G | 1 |
2 other study(ies) available for glycyl-arginyl-glycyl-aspartyl-seryl-proline and Lung Neoplasms
Article | Year |
---|---|
Inhibition of cell attachment, invasion and metastasis of human carcinoma cells by anti-integrin beta 1 subunit antibody.
Topics: Animals; Antibodies, Monoclonal; Carcinoma; Cell Adhesion; Extracellular Matrix Proteins; Humans; Integrin beta1; Integrins; Liver Neoplasms; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Neoplasm Metastasis; Oligopeptides; Tumor Cells, Cultured | 1992 |
Inhibition of experimental metastasis of murine fibrosarcoma cells by oligopeptide analogues to the fibronectin cell-binding site.
Topics: Animals; Cell Adhesion; Cell Line; Enzyme-Linked Immunosorbent Assay; Fibrosarcoma; Lung Neoplasms; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Neoplasm Transplantation; Oligopeptides; Receptors, Fibronectin; Receptors, Immunologic | 1989 |